There is capital sitting on the sidelines, but founders and CEOs should realize that investors are digging into their due diligence. The “wow” factor and potential size of the medtech market matter much less now than solid fundamentals.
The COVID-19 pandemic exposed the necessity of virtual care and revealed its possibility as a more efficient means of administering treatment in an overwhelmed and understaffed infrastructure. Its fast-paced adoption highlighted the need for global standards and third-party certifications.
The second part of this two-article series on digital therapeutics (DTx) sheds light on challenges faced by the companies in the DTx market and outlines hurdles that must be overcome to achieve success.
Combining imaging technology with artificial intelligence can help address both challenges in healthcare disparities as well as in patient care.
MedExecWomen board President, Helen Routh, noted at a recent conference: “Innovation in healthcare, particularly post-COVID, requires us to work across industry sectors, alongside clinicians and payers.” Laurie Halloran, president & CEO of Halloran Consultant Group shares insights she heard from a panel of strong female leaders on how the industry can take action to improve health inequities, which will be an ongoing topic at future conferences.
How can AI become a beneficial medical device manufacturing technology? This article reviews some examples of how it excels.
A review of the top six reasons there has been a dramatic increase in the adoption of remote care among seniors.
Outdated policies and regulations threatens to bring progress to a standstill, restrict vital telehealth access to millions of Americans, and exacerbate health inequities.
Blockchain technology helps support the goal of decentralizing the healthcare sector and providing patients with the information they deserve about their own healthcare data.
The combination of medtech progress with strides in modern healthcare interoperability will enable preventive care in unprecedented ways.